Tuberculosis and diabetes co-morbidity: an unresolved problem

Authors

  • César Ugarte-Gil Universidad Peruana Cayetano Heredia. Lima, Perú. Johns Hopkins Bloomberg School of Public Health. Baltimore, EE. UU. Médico cirujano. master en Epidemiología.
  • David AJ Moore Universidad Peruana Cayetano Heredia. Lima, Perú. London School of Hygiene and Tropical Medicine. Londres, Reino Unido. master en Epidemiología. médico infectólogo.

DOI:

https://doi.org/10.17843/rpmesp.2014.311.20

Keywords:

Tuberculosis, Diabetes mellitus, Comorbidity

Abstract

Co-morbidity between tuberculosis and diabetes has been described since the early 20th century. In developed countries, where there has been a decrease of infectious diseases with an increase of non-communicable diseases, as well as those countries who still have a high prevalence of infectious diseases but an increase of non-communicable diseases, it is observed that the prevalence of co-morbidity between tuberculosis and diabetes is increasing, making clinical management and control at the public health level a new challenge for health systems. This review aims to show the current available evidence that can inform research lines being developed to understand the problem. In countries like Peru, where there is an epidemiological transition, further research could allow us to understand and describe in a better way the characteristics and impact of this co-morbidity.

Downloads

Download data is not yet available.

Published

2014-03-18

Issue

Section

Special Section

How to Cite

1.
Ugarte-Gil C, AJ Moore D. Tuberculosis and diabetes co-morbidity: an unresolved problem. Rev Peru Med Exp Salud Publica [Internet]. 2014 Mar. 18 [cited 2024 Dec. 10];31(1). Available from: https://rpmesp.ins.gob.pe/index.php/rpmesp/article/view/20

Most read articles by the same author(s)